Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment

Carbohydr Polym. 2022 Mar 15:280:119021. doi: 10.1016/j.carbpol.2021.119021. Epub 2021 Dec 22.

Abstract

This study developed folic acid (FA) conjugated chitosan (CS) encapsulated rutin (R) synthesized palladium nanoclusters (Pd NCs) for NIR triggered and folate receptor (FR) targeted triple-negative breast cancer (MDA-MB 231 cells) treatment. R-Pd NCs exhibited flower-shaped particles with an average size of <100 nm. FA-CS encapsulation concealed the flower shape of R-Pd NCs with a positive charge. The XRD spectrum confirmed the cubic crystalline structure of Pd. The FA conjugation on CS improved the cellular uptake of R-Pd NCs in MDA-MB 231 cells was confirmed by TEM. FA-CS-R-Pd NCs (+NIR) treatment was considerably inhibited the MDA-MB 231 cells proliferation evidenced by cell viability, fluorescent staining, and flow cytometry analysis. Further, in vitro hemolysis assay and in Ovo model confirmed the non-toxic nature of FA-CS-R-Pd-NCs with or without NIR radiation. Hence, this study concluded that FA-CS-R-Pd NCs can be applied for the treatment of drug-resistant breast cancer.

Keywords: Breast cancer; Chitosan; Folic acid; Nanocluster; Palladium; Rutin.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Cell Line, Tumor
  • Cell Survival
  • Chitosan / chemistry*
  • Drug Carriers*
  • Folic Acid / chemistry*
  • HEK293 Cells
  • Humans
  • Light
  • Nanoparticles / chemistry
  • Palladium / administration & dosage*
  • Rutin / chemistry
  • Temperature
  • Triple Negative Breast Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Rutin
  • Palladium
  • Chitosan
  • Folic Acid